D-1471-2016 Class III Terminated

Recalled by Actavis Inc — Parsippany, NJ

FDA drug recall D-1471-2016 was initiated by Actavis Inc on Aug 2, 2016 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: Out of specification (OOS) results for related compound G were obtained at 12-month (at expiry) stability time-point for room temperature sample(s). The recall status is terminated (terminated Feb 8, 2017). Affected quantity: 672 bottles.

Recall details

Product Type
Drugs
Report Date
Aug 31, 2016
Initiation Date
Aug 2, 2016
Termination Date
Feb 8, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
672 bottles

Product description

Acetasol HC (hydrocortisone and acetic acid otic solution USP) , Rx Only, 10 mL bottle, Manufactured by: Actavis Midatlantic LLC 1877 Kawai Road Lincolnton, NJ 28092 USA, NDC 0472-0882-82

Reason for recall

Failed Impurities/Degradation Specifications: Out of specification (OOS) results for related compound G were obtained at 12-month (at expiry) stability time-point for room temperature sample(s).

Distribution pattern

Nationwide and Puerto Rico

Code information

L503092, Exp 04/2016

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1471-2016
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1471-2016. Report a data issue: hello@regdatalab.com.